Analysis of DR Progression to Identify Risks and Need for Treatment
- Sponsor
- Association for Innovation and Biomedical Research on Light and Image
- Study ID
- NCT07417410
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 35 Years - 90 Years
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to understand whether vascular and structural changes in the eyes caused by diabetes can help predict which people are more likely to experience worsening diabetic retinopathy (a diabetes-related eye disease) and how these eye changes are related to cardiovascular complications. The study will include about 1,000 people with type 2 diabetes, aged 35 to 90 years, and will take place over twelve months. It may also include a retrospective component, where existing medical and imaging data collected from previous visits (within the last 1 to 5 years) will be analyzed. The main questions it aims to answer are: * Can eye vessel and tissue changes, observed through modern imaging techniques and clinical data, help better describe and predict which cases of diabetic retinopathy will become more severe? * Can these same eye changes help predict the presence and risk of cardiovascular problems-such as heart disease or stroke-in people living with type 2 diabetes?
Key Dates
- First listed
- Feb 18, 2026
- Start date
- Nov 3, 2025
- Status verified
- Feb 2026
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Change in Diabetic Retinopathy Staging [ Time Frame: Baseline to 12 months ]
Central Contacts
- Joana F Tavares, PhD239480137
- Liliana C Soares, MsC239480115
Find similar trials
Related Studies
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Human iPSC for Repair of Vasodegenerative Vessels in Diabetic RetinopathyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama